» Articles » PMID: 10629063

Exonic Splicing Enhancer Motif Recognized by Human SC35 Under Splicing Conditions

Overview
Journal Mol Cell Biol
Specialty Cell Biology
Date 2000 Jan 11
PMID 10629063
Citations 102
Authors
Affiliations
Soon will be listed here.
Abstract

Exonic splicing enhancers (ESEs) are important cis elements required for exon inclusion. Using an in vitro functional selection and amplification procedure, we have identified a novel ESE motif recognized by the human SR protein SC35 under splicing conditions. The selected sequences are functional and specific: they promote splicing in nuclear extract or in S100 extract complemented by SC35 but not by SF2/ASF. They can also function in a different exonic context from the one used for the selection procedure. The selected sequences share one or two close matches to a short and highly degenerate octamer consensus, GRYYcSYR. A score matrix was generated from the selected sequences according to the nucleotide frequency at each position of their best match to the consensus motif. The SC35 score matrix, along with our previously reported SF2/ASF score matrix, was used to search the sequences of two well-characterized splicing substrates derived from the mouse immunoglobulin M (IgM) and human immunodeficiency virus tat genes. Multiple SC35 high-score motifs, but only two widely separated SF2/ASF motifs, were found in the IgM C4 exon, which can be spliced in S100 extract complemented by SC35. In contrast, multiple high-score motifs for both SF2/ASF and SC35 were found in a variant of the Tat T3 exon (lacking an SC35-specific silencer) whose splicing can be complemented by either SF2/ASF or SC35. The motif score matrix can help locate SC35-specific enhancers in natural exon sequences.

Citing Articles

Alternative Splicing: A Potential Therapeutic Target in Hematological Malignancies.

Temaj G, Chichiarelli S, Saha S, Telkoparan-Akillilar P, Nuhii N, Hadziselimovic R Hematol Rep. 2024; 16(4):682-697.

PMID: 39584923 PMC: 11587037. DOI: 10.3390/hematolrep16040066.


Splicing the Difference: Harnessing the Complexity of the Transcriptome in Hematopoiesis.

Maul-Newby H, Halene S Exp Hematol. 2024; 140():104655.

PMID: 39393608 PMC: 11732257. DOI: 10.1016/j.exphem.2024.104655.


Molecular impact of mutations in RNA splicing factors in cancer.

Zhang Q, Ai Y, Abdel-Wahab O Mol Cell. 2024; 84(19):3667-3680.

PMID: 39146933 PMC: 11455611. DOI: 10.1016/j.molcel.2024.07.019.


The U1-70K and SRSF1 interaction is modulated by phosphorylation during the early stages of spliceosome assembly.

Paul T, Zhang P, Zhang Z, Fargason T, De Silva N, Powell E Protein Sci. 2024; 33(8):e5117.

PMID: 39023093 PMC: 11255866. DOI: 10.1002/pro.5117.


circSMARCA5 Is an Upstream Regulator of the Expression of miR-126-3p, miR-515-5p, and Their mRNA Targets, () and () in Glioblastoma.

Merulla A, Stella M, Barbagallo C, Battaglia R, Caponnetto A, Broggi G Int J Mol Sci. 2022; 23(22).

PMID: 36430152 PMC: 9690846. DOI: 10.3390/ijms232213676.


References
1.
Tian M, Maniatis T . A splicing enhancer complex controls alternative splicing of doublesex pre-mRNA. Cell. 1993; 74(1):105-14. DOI: 10.1016/0092-8674(93)90298-5. View

2.
Chew S, Liu H, Mayeda A, Krainer A . Evidence for the function of an exonic splicing enhancer after the first catalytic step of pre-mRNA splicing. Proc Natl Acad Sci U S A. 1999; 96(19):10655-60. PMC: 17938. DOI: 10.1073/pnas.96.19.10655. View

3.
Lavigueur A, La Branche H, Kornblihtt A, Chabot B . A splicing enhancer in the human fibronectin alternate ED1 exon interacts with SR proteins and stimulates U2 snRNP binding. Genes Dev. 1993; 7(12A):2405-17. DOI: 10.1101/gad.7.12a.2405. View

4.
Stormo G . Consensus patterns in DNA. Methods Enzymol. 1990; 183:211-21. DOI: 10.1016/0076-6879(90)83015-2. View

5.
Ge H, Zuo P, Manley J . Primary structure of the human splicing factor ASF reveals similarities with Drosophila regulators. Cell. 1991; 66(2):373-82. DOI: 10.1016/0092-8674(91)90626-a. View